# 4Tissue raises €7M for resorbable breast implant trials

> 4Tissue gets €7.8m to test dissolving breast implants in humans.
- Title: 4Tissue raises €7M for resorbable breast implant trials
- Summary: 4Tissue gets €7.8m to test dissolving breast implants in humans. 4Tissue raised €7 million to begin first-in-human testing of a resorbable breast implant…
- Keywords: 4tissue, resorbable breast implant, first-in-human testing, breast reconstruction, hydrogel scaffold, tissue growth, startups, business, raises, resorbable, breast, implant
- Source: Dealroom — https://dealroom.co/news/164132-4tissue-raises-7m-to-test-resorbable-breast-implant-in-humans
- Published: 2026-10-20T04:42:17+00:00
- Read time: 1 min
- Topics: 4tissue, resorbable breast implant, first-in-human testing, breast reconstruction, hydrogel scaffold, tissue growth, startups, business
## What's the deal?
Ghent-based biotech 4Tissue has raised €7 million ($7.8 million) to begin first-in-human testing of a breast implant designed to break down inside the body.
## What's the endgame?
4Tissue is developing an injectable approach that combines a hydrogel scaffold with cells to help a patient's own tissue grow, then dissolves leaving natural tissue.
## Why now?
The raise moves the concept from lab to clinical evaluation, with human testing marking the next milestone for an alternative to permanent implants and flap surgery.
## Key takeaway

4Tissue raised €7 million to begin first-in-human testing of a resorbable breast implant designed to break down inside the body.